Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
46.00
-0.16 (-0.35%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Company Description

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States.

The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.

It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.

Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Inari Medical, Inc.
Inari Medical logo
Country United States
Founded 2011
IPO Date May 22, 2020
Industry Medical Devices
Sector Healthcare
Employees 1,300
CEO Andrew J. Hykes

Contact Details

Address:
6001 Oak Canyon, Suite 100
Irvine, California 92618
United States
Phone 949-923-4747
Website inarimedical.com

Stock Details

Ticker Symbol NARI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $19.00
CIK Code 0001531048
CUSIP Number 45332Y109
ISIN Number US45332Y1091
Employer ID 45-2902923
SIC Code 3841

Key Executives

Name Position
Andrew J. Hykes Chief Executive Officer, President and Director
Mitchell C. Hill Chief Financial Officer
Dr. Thomas M. Tu M.D. Chief Medical Officer
Paul A. Koehn Senior Vice President of Operations
Kevin Strange Senior Vice President of Finance, Accounting, Strategy and Business Development
John Hsu C.F.A. Vice President of Investor Relations
Angela Ahmad General Counsel and Secretary
Eric Khairy Senior Vice President of Marketing
John R. Borrell Senior Vice President of Sales
Tara Dunn Senior Vice President and GM of LimFlow

Latest SEC Filings

Date Type Title
Jun 12, 2024 144 Filing
May 31, 2024 SD Form - SD
May 28, 2024 144 Filing
May 28, 2024 144 Filing
May 20, 2024 144 Filing
May 16, 2024 144 Filing
Apr 30, 2024 10-Q Quarterly Report
Apr 30, 2024 8-K Current Report
Apr 25, 2024 8-K Current Report
Apr 3, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals